Celsion Corporation (CLN) Issues Statement Regarding Misleading Blog Entry
6/13/2013 9:23:16 AM
More...
|
Celsion Corporation (CLN) Announces $9.83 Million Registered Direct Offering
5/31/2013 10:01:39 AM
More...
|
Celsion Corporation (CLN) Announces ThermoDox® HEAT Study Findings to be Presented at the 2013 European Conference on Interventional Oncology(ECIO) in Budapest, Hungary on June 19 and 20, 2013
5/30/2013 10:14:22 AM
More...
|
Celsion Corporation (CLN) Announces Issuance of Additional Patents Covering ThermoDox® Technologies
5/22/2013 10:10:28 AM
More...
|
Celsion Corporation (CLN)'s ThermoDox® HEAT Study Findings Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO)
5/17/2013 7:05:00 AM
More...
|
Celsion Corporation (CLN) Reports First Quarter 2013 Financial Results and Provides Business Update
5/9/2013 7:07:37 AM
More...
|
Celsion Corporation (CLN) Announces ThermoDox® HEAT Study Findings to be Reviewed at the 9th Annual World Conference on Interventional Oncology (WCIO) in New York City on May 16, 2013
5/1/2013 10:29:36 AM
More...
|
Celsion Corporation (CLN) to Hold First Quarter 2013 Financial Results Conference Call on Thursday, May 9, 2013
5/1/2013 6:59:40 AM
More...
|
Celsion Corporation (CLN) Strengthens Board of Directors With Addition of Pharma/Biotech Industry Veteran Fredric Price
4/30/2013 11:22:48 AM
More...
|
Celsion Corporation (CLN) Provides Business Update
4/23/2013 9:53:32 AM
More...
|
|